HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Shi, W.-X. Articles by Varki, A. Search for Related Content PubMed PubMed Citation Articles by Shi, W.-X. Articles by Varki, A. Social Bookmarking                      What's this?

Volume 271, Number 49, Issue of December 6, 1996 pp. 31517-31525
©1996 by The American Society for Biochemistry and Molecular Biology, Inc.

---

Regulation of Sialic Acid 9-O-Acetylation during the Growth and Differentiation of Murine Erythroleukemia Cells

(Received for publication, September 3, 1996)

From the Glycobiology Program, UCSD Cancer Center, the Division of Cellular and Molecular Medicine, University of California, San Diego, La Jolla, California 92093

Sialic acids are typically found at the terminal position on vertebrate oligosaccharides. They are sometimes modified by an O-acetyl ester at the 9-position, potentially altering recognition of sialic acid by antibodies, lectins, and viruses. 9-O-Acetylation is known to be selectively expressed on gangliosides in melanoma cells and on N-linked chains in hepatocytes. Using a recently developed probe, we show here that in murine erythroleukemia cells, this modification is selectively expressed on another class of oligosaccharides, O-linked chains carried on cell surface sialomucins. These cells also express 9-O-acetylation on the ganglioside G_D3, but this modification appears to be undetectable on the cell surface. Increasing cell density in culture is associated with a decrease in cell surface 9-O-acetylation of sialomucins. This change correlates with the spontaneous differentiation toward a mature erythroid phenotype. This down-regulation upon differentiation and entry into the G₀/G₁ stage of the cell cycle is confirmed by differentiation-inducing agents. In contrast, cells arrested in G₂/M by the microtubule depolymerizing agent nocodazole show increased expression of cell surface 9-O-acetylated sialomucins (but not the 9-O-acetylated ganglioside). However, the microtubule stabilizer taxol does not induce this increase, showing that the nocodazole effect is independent of cell cycle stage. Indeed, direct analysis showed no correlation of 9-O-acetylation with cell cycle stage in rapidly growing cells, and shorter treatments with nocodazole also increased expression. Western blots of cell extracts confirmed that changes caused by differentiation and nocodazole are not due to redistribution of molecules from the cell surface. Indeed, following selective removal of 9-O-acetyl groups from the cell surface by a specific esterase, the recovery of expression is mediated by new synthesis rather than by redistribution from an internal pool. Thus, 9-O-acetylation on these sialomucins appears to be primarily regulated by the rate of synthesis, and the increase with nocodazole treatment is likely due to the inhibition of turnover of cell surface molecules. These data show that 9-O-acetylation of sialic acids in murine erythroleukemia cells is a highly regulated modification, being selectively expressed in a cell type-specific manner on certain classes of oligosaccharides and differentially regulated with regard to subcellular localization and to the state of cellular differentiation.

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				H. Satake, H. Y. Chen, and A. Varki Genes Modulated by Expression of GD3 Synthase in Chinese Hamster Ovary Cells. EVIDENCE THAT THE Tis21 GENE IS INVOLVED IN THE INDUCTION OF GD3 9-O-ACETYLATION J. Biol. Chem., February 28, 2003; 278(10): 7942 - 7948. [Abstract] [Full Text] [PDF]

				L. T. Martin, J. D. Marth, A. Varki, and N. M. Varki Genetically Altered Mice with Different Sialyltransferase Deficiencies Show Tissue-specific Alterations in Sialylation and Sialic Acid 9-O-Acetylation J. Biol. Chem., August 30, 2002; 277(36): 32930 - 32938. [Abstract] [Full Text] [PDF]

				S. Pal, M. Chatterjee, D. K. Bhattacharya, S. Bandhyopadhyay, and C. Mandal Identification and purification of cytolytic antibodies directed against O-acetylated sialic acid in childhood acute lymphoblastic leukemia Glycobiology, June 1, 2000; 10(6): 539 - 549. [Abstract] [Full Text] [PDF]

				Y. Zhang and Y. C. Lee Acid-catalyzed Lactonization of alpha 2,8-Linked Oligo/Polysialic Acids Studied by High Performance Anion-exchange Chromatography J. Biol. Chem., March 5, 1999; 274(10): 6183 - 6189. [Abstract] [Full Text] [PDF]

				M. Krishna and A. Varki 9-O-Acetylation of Sialomucins: A Novel Marker of Murine CD4 T Cells that Is Regulated during Maturation and Activation J. Exp. Med., June 2, 1997; 185(11): 1997 - 2013. [Abstract] [Full Text] [PDF]